Bedside’s newsletters are the fastest way to keep up with health and medicine. Start with The Chart, then add the beats you follow.
Our newsletters
- The Chart. Our flagship, every weekday at 6 a.m. Eastern. Hannah Gerber and the newsroom on the stories that matter that morning, in about five minutes.
- The Pipeline. Thursdays. Nadia Okafor on biotech deals, trials and the people behind new medicines.
- The Docket. Tuesdays. Thea Lindqvist on the FDA, Medicare and Congress, and what each move means for patients.
- Second Opinion. Sundays. The week’s essays from doctors, nurses, researchers and patients.
Sign up below with your email. Then pick your sections on your account page: only care about biotech and policy? We’ll send you those and leave the rest out.
Recent stories
- Hospitals are selling longevity now. Some of their own doctors have doubts
- ¡Hola, mundo!
- FDA advisers split on a twice-yearly cholesterol shot, citing thin data in older patients
- Merriden will buy Halvard Bio for $2.1 billion after its kidney drug clears a key trial
- Drug company meals for doctors track with more prescriptions of a pricey inhaler, analysis finds
Already subscribed? Manage your account.